Home The Activities of Some Glycosaminoglycan-Degrading Enzymes in the Wall of the Umbilical Cord Artery and Their Alteration in Edema, Proteinuria, Hypertension (EPH)-Gestosis
Article
Licensed
Unlicensed Requires Authentication

The Activities of Some Glycosaminoglycan-Degrading Enzymes in the Wall of the Umbilical Cord Artery and Their Alteration in Edema, Proteinuria, Hypertension (EPH)-Gestosis

  • Lech Romanowicz , Edward Bańkowski and Stefan Jaworski
Published/Copyright: June 1, 2005
Become an author with De Gruyter Brill
Clinical Chemistry and Laboratory Medicine (CCLM)
From the journal Volume 37 Issue 4

Abstract

Edema, proteinuria, hypertension (EPH)-gestosis is associated with a premature replacement of hyaluronic acid by sulphated glycosaminoglycans (GAGs), both in the umbilical cord arteries (UCAs) and in Wharton's jelly. This phenomenon may be considered as a sign of premature ageing of the umbilical cord tissues. The decrease in hyaluronic acid content in the UCA was found to be the result of reduced biosynthesis of this substance, whereas an increase in sulphated GAGs-content is rather a result of slower degradation of newly synthesised GAGs. In this study the activities of GAGs-degrading enzymes in normal umbilical cord arteries and those taken from newborns delivered by mothers with EPH-gestosis were compared. It was found that EPH-gestosis results in a significant reduction in the activities of neutral endoglycosidases degrading most of the sulphated glycosaminoglycans (with the exception of heparan sulphate). The activities of exoglycosidases also decrease but to a lesser degree. These alterations are thought to be responsible for EPH-gestosis-associated accumulation of sulphated glycosaminoglycans in the extracellular matrix of the arterial wall. Such remodelling of the arterial wall may affect foetal blood circulation. The significance of these phenomena in the phathological mechanism of EPH-gestosis is discussed.

:
Published Online: 2005-06-01
Published in Print: 1999-04-01

Copyright (c)1999 by Walter de Gruyter GmbH & Co. KG

Articles in the same Issue

  1. Serum Amyloid A (SAA): a Concise Review of Biology, Assay Methods and Clinical Usefulness
  2. Serum Cystatin C as an Endogenous Marker of the Renal Function – a Review
  3. Improved Fluorescent PCR-Based Assay for Sizing CGG Repeats at the FRAXA Locus
  4. The Influence of Radiation and Chemotherapy-Related DNA Strand Breaks on Carcinogenesis: An Evaluation
  5. A Simple HPLC Method for Monitoring Mycophenolic Acid and Its Glucuronidated Metabolite in Transplant Recipients
  6. The Activities of Some Glycosaminoglycan-Degrading Enzymes in the Wall of the Umbilical Cord Artery and Their Alteration in Edema, Proteinuria, Hypertension (EPH)-Gestosis
  7. Endothelin-1- and Endothelin-Receptors in Lung Biopsies of Patients with Pulmonary Hypertension due to Congenital Heart Disease
  8. Increased Serum Neopterin Concentrations in Patients with Alzheimer’s Disease
  9. Biomarkers of Bone Turnover and Bone Mineral Density in Hyperprolactinemic Amenorrheic Women
  10. Age Relationships and Sex Differences in Serum Levels of Pregnenolone and 17-Hydroxypregnenolone in Normal Subjects
  11. A Study of Hypermagnesaemia in a Hospital Population
  12. Multiple Regression Analysis of Interference Effects from a Hemoglobin-Based Oxygen Carrier Solution
  13. Serum Ionized Magnesium: Comparison of Results Obtained with Three Ion-Selective Analyzers
  14. Automated Prozone Effect Detection in Ferritin Homogeneous Immunoassays Using Neural Network Classifiers
  15. Recent Activities of EC4 in the Harmonization of Clinical Chemistry in the European Union
  16. Preventing Coronary Artery Disease. Cardioprotective Therapeutics in Practice. Edited by M. J. Kendall and R. C. Horton
  17. Will Medical Schools Remain what They Are? Medical Education in the Millennium. Edited by Brian Jolly and Lesley Rees
Downloaded on 18.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/CCLM.1999.068/html
Scroll to top button